201 related articles for article (PubMed ID: 1649252)
21. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
Samantaray S; Mohanakumar KP
Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
[TBL] [Abstract][Full Text] [Related]
22. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
[TBL] [Abstract][Full Text] [Related]
23. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP.
O'Callaghan JP; Miller DB; Reinhard JF
Neurosci Lett; 1990 Sep; 117(1-2):228-33. PubMed ID: 1981254
[TBL] [Abstract][Full Text] [Related]
24. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
Mitsumoto Y; Mori A
Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
[TBL] [Abstract][Full Text] [Related]
25. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
O'Callaghan JP; Martin PM; Mass MJ
Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
[TBL] [Abstract][Full Text] [Related]
26. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
27. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
28. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
29. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Irwin I; Langston JW; DeLanney LE
Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
[TBL] [Abstract][Full Text] [Related]
30. The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Bonuccelli U; Garant D; Fariello R
Neurosci Lett; 1991 Mar; 124(1):22-6. PubMed ID: 1713316
[TBL] [Abstract][Full Text] [Related]
31. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Yurek DM; Deutch AY; Roth RH; Sladek JR
Brain Res; 1989 Sep; 497(2):250-9. PubMed ID: 2573405
[TBL] [Abstract][Full Text] [Related]
32. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
Cosi C; Marien M
Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
Wu WR; Zhu ZT; Zhu XZ
Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
[TBL] [Abstract][Full Text] [Related]
34. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
[TBL] [Abstract][Full Text] [Related]
35. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
36. Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice.
Fung YK; Fiske LA; Lau YS
Gen Pharmacol; 1991; 22(4):669-72. PubMed ID: 1936899
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
Sagi Y; Weinstock M; Youdim MB
J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
[TBL] [Abstract][Full Text] [Related]
38. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase.
O'Callaghan JP; Seidler FJ
Neurosci Lett; 1992 Dec; 148(1-2):105-8. PubMed ID: 1300481
[TBL] [Abstract][Full Text] [Related]
39. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
[TBL] [Abstract][Full Text] [Related]
40. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
McGrew DM; Irwin I; Langston JW
Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
